Print

Active Biotech - Annual Report 2003

2004-04-02

The printed Annual Report is now distributed by mail to the shareholders who have requested it. It can also be ordered from the Company.
The English Annual Report will be available at the web site on Wednesday, April 7.
You will find the Swedish Annual Report here:
Lund, April 2, 2004
Active Biotech AB (publ)
Active Biotech AB is a biotechnology company focusing on research in and development of pharmaceuticals. Active Biotech has a strong R&D portfolio and pipeline products with focus primarily on autoimmune/ inflammatory diseases and cancer. Most advanced projects include orally administered small molecules with unique immunomodulatory properties that can be used to treat autoimmune and inflammatory diseases, as well as a novel concept for use in cancer immunotherapy.
Active Biotech AB
Box 724, SE-220 07 Lund, Sweden
Tel: +46 (0)46-19 20 00
Fax: +46 (0)46-19 20 50

pdf



Back